~~<i id='24D08D11FC'><strike id='24D08D11FC'><tt id='24D08D11FC'><pre id='24D08D11FC'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：comprehensive 2025-10-02 14:12:04 Page View：18576

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Dobbs anniversary: the lost opportunity of abortion as health care

leisure time

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Dairy farmers resist CDC push for PPE against bird flu virus

ARIANADREHSLER/AFPviaGettyImagesWASHINGTON—TheCentersforDiseaseControlandPreventionrecommendedthiswe

Virginia high school admissions case could be legal follow

3:24DemonstratorsprotestoutsideoftheSupremeCourtinWashington,Thursday,June29,2023,aftertheSupremeCou

First recipient of genetically engineered pig kidney has died

RickSlayman,holdinghandswithhispartner,Faren,poseswithmembersofhisMassachusettsGeneralHospitalmedica